Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronnie T Poon

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 3, 2004
Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18Jane M Blazeby, Elspeth Currie, Benny C Y Zee, et al.
Annals of Surgery|March 17, 2004
Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institutionRonnie T Poon, Kelvin K Ng, Chi Ming Lam, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 31, 2005
Selective portal vein clamping for radiofrequency ablation of hepatocellular carcinoma with portal vein invasionKenneth S Chok, Kenneth C Ng, Chi Ming Lam, et al.
Archives of Surgery (Chicago, Ill. : 1960)|March 22, 2006
Safety limit of large-volume hepatic radiofrequency ablation in a rat modelKelvin K Ng, Chi Ming Lam, Ronnie T Poon, et al.
Cancer|December 25, 2008
Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor responseThomas Yau, Pierre Chan, Kelvin K Ng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Up-regulation of vascular endothelial growth factor (VEGF) in small-for-size liver grafts enhances macrophage activities through VEGF receptor 2-dependent pathwayZhen Fan Yang, Ronnie T Poon, Ying Luo, et al.
Investigational New Drugs|March 10, 2012
Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory diseaseThomas Yau, Hilda Wong, Pierre Chan, et al.
Omics : a Journal of Integrative Biology|February 16, 2011
Global regulation on microRNA in hepatitis B virus-associated hepatocellular carcinomaAngela M Liu, Chunsheng Zhang, Julja Burchard, et al.
Journal of Surgical Oncology|August 31, 2004
Management of hepatocellular carcinoma in renal transplant recipientsKenneth S Chok, Chi Ming Lam, Fu Keung Li, et al.
Archives of Surgery (Chicago, Ill. : 1960)|November 23, 2006
Therapeutic potential of cardiotrophin 1 in fulminant hepatic failure: dual roles in antiapoptosis and cell repairDavid W Ho, Zhen Fan Yang, Chi Keung Lau, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|November 3, 2004
Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18Jane M Blazeby, Elspeth Currie, Benny C Y Zee, et al.
Annals of Surgery|March 17, 2004
Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institutionRonnie T Poon, Kelvin K Ng, Chi Ming Lam, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 31, 2005
Selective portal vein clamping for radiofrequency ablation of hepatocellular carcinoma with portal vein invasionKenneth S Chok, Kenneth C Ng, Chi Ming Lam, et al.
Archives of Surgery (Chicago, Ill. : 1960)|March 22, 2006
Safety limit of large-volume hepatic radiofrequency ablation in a rat modelKelvin K Ng, Chi Ming Lam, Ronnie T Poon, et al.
Cancer|December 25, 2008
Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor responseThomas Yau, Pierre Chan, Kelvin K Ng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Up-regulation of vascular endothelial growth factor (VEGF) in small-for-size liver grafts enhances macrophage activities through VEGF receptor 2-dependent pathwayZhen Fan Yang, Ronnie T Poon, Ying Luo, et al.
Investigational New Drugs|March 10, 2012
Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory diseaseThomas Yau, Hilda Wong, Pierre Chan, et al.
Omics : a Journal of Integrative Biology|February 16, 2011
Global regulation on microRNA in hepatitis B virus-associated hepatocellular carcinomaAngela M Liu, Chunsheng Zhang, Julja Burchard, et al.
Journal of Surgical Oncology|August 31, 2004
Management of hepatocellular carcinoma in renal transplant recipientsKenneth S Chok, Chi Ming Lam, Fu Keung Li, et al.
Archives of Surgery (Chicago, Ill. : 1960)|November 23, 2006
Therapeutic potential of cardiotrophin 1 in fulminant hepatic failure: dual roles in antiapoptosis and cell repairDavid W Ho, Zhen Fan Yang, Chi Keung Lau, et al.
Pageof 9